secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001628280-24-035171
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q2 revenue up 39% to $1.48B but net loss widens to $31M
---------------------------------------------------------------------

- Revenue $1.48B (+39% YoY); MA membership 513K (+38%).
- Net loss $31M vs $17M loss year ago; gross profit fell to $32M from $55M.
- Medical margin $106M (down 21% YoY); Adjusted EBITDA loss $3M vs $12M gain.
- Retroactive termination of unprofitable contracts cut membership by 17K and revenue by $110M.
- Maintains FY2024 medical margin ($400-450M) and Adjusted EBITDA (-$60 to -$15M) guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828024035171/0001628280-24-035171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828024035171/agl-20240806.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-035171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer